Radius Health's ($RDUS) shares slipped on Tuesday after the company said it was postponing a planned FDA filing for its osteoporosis drug. But CEO Robert Ward ...
The names of the persons filing this statement on Schedule 13G are Tourbillon Capital Partners, L.P. (“Tourbillon Capital Partners”) and Jason H. Karp (together, the “Reporting Persons”). Mr. Karp is ...
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results